GG 167

Known as: GG-167, GG167 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1994-2009
02419942009

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
We have recently reported an influenza virus neuraminidase inhibitor, RWJ-270201 (BCX-1812), a novel cyclopentane derivative… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
1999
1999
The virulent influenza virus clone 7a produced a greater level of apoptosis in MDCK cells compared with the attenuated strain A… (More)
Is this relevant?
1999
1999
The study was carried out to evaluate the therapeutic effects of zanamivir, a highly selective, potent and specific inhibitor of… (More)
Is this relevant?
1998
1998
We have recently described GS 4071, a carbocyclic transition-state analog inhibitor of the influenza virus neuraminidase, which… (More)
Is this relevant?
1998
1998
The carbocyclic transition state sialic acid analog GS4071 ([3R,4R,5S]-4-acetamido-5-amino-3-[1-ethylpropoxy]-1-cyclohexane-1… (More)
Is this relevant?
1998
1998
An oral prodrug of GS 4071, a potent and selective inhibitor of influenza neuraminidases, is currently under clinical development… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
BACKGROUND The sialic acid analogue zanamivir (GG167) is a selective inhibitor of influenza A and B virus neuraminidases. These… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Here we report the isolation of influenza virus A/turkey/Minnesota/833/80 (H4N2) with a mutation at the catalytic residue of the… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
OBJECTIVE The current study evaluated whether intranasal administration of the sialic acid analog 4-guanidino-Neu5Ac2en (GG167… (More)
Is this relevant?
1995
1995
GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is a novel viral neuraminidase (sialidase) inhibitor which… (More)
Is this relevant?